	Correction: Development of a process model of posttraumatic growth in psychosis: a qualitative study. Front Psychiatry Frontiers Production Office. PMID: 42052539 [PubMed]
	Brexpiprazole for Agitation in Patients with Alzheimer's Dementia with and without Co-Occurring Psychosis: Post Hoc Analysis of Short- and Long-Term Trials. Neuropsychiatr Dis Treat Tariot PN, Chumki SR, Wang D, Such P, Palma AM, Zhang Z, Montano CB. PMID: 42052145 [PubMed]
	Cognitive impairment preceding the onset of the first psychosis episode in schizophrenia. Mol Psychiatry Reichenberg A, Kahn RS. PMID: 42050012 [PubMed - as supplied by publisher]
	Cannabidiol for the treatment of positive and negative symptoms in schizophrenia spectrum disorders: a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci Di Francesco A, Cutrufelli P, Chiarenza C, Zambuto L, Concerto C, Mineo L, Petralia A, Catalfo M, Rodolico A, Samara M, Leucht S, Caraci F, Signorelli MS. PMID: 42047775 [PubMed - as supplied by publisher]
	The correlation between polymorphism of interleukin 3 receptor alpha Rs6603272 G/T gene with negative symptoms in Bataknese schizophrenia patients. Med Glas (Zenica) Asrika Asrul D, Effendy E, Mahmud Amin M, Camellia V, Yamamoto Z. PMID: 42047070 [PubMed - indexed for MEDLINE]
	The effects of rTMS over orbitofrontal cortex on cognitive functions in first-episode schizophrenia. Psychol Med Hu Q, Jiao X, Ding Y, Wei Y, Tang X, Xu L, Cui H, Tang Y, Liu H, Gao J, Zeng L, Yi Z, Li C, Chen J, Wang J, Zhang T. PMID: 42046881 [PubMed - indexed for MEDLINE]
	Understanding the burden of cognitive impairment associated with schizophrenia: results from the international LUCIA study. Eur Psychiatry Correll CU, Galderisi S, Artés M, Fernández A, Kappelhoff B, Lawhorn WD, Tulliez S, Ikezawa S, Konradsson-Geuken Å, Morgane SH, Skau K, van der Weijden-Germann M, McCutcheon RA. PMID: 42046196 [PubMed - as supplied by publisher]
	[Labor inclusion and medicalization: neuroleptics as actants in the experiences of workers diagnosed with schizophrenia in Chile]. Salud Colect Bouey Vargas E, Reyes Andreani MJ. PMID: 42044875 [PubMed - indexed for MEDLINE]
	Echoes of Trauma: The Impact of Hippocampal Impairments on Reward and Motivational Dysfunction in Psychosis. Neurosci Biobehav Rev O'Brien KJ, Elliott BL, Ered A, Murty VP, Ellman LM. PMID: 42044757 [PubMed - as supplied by publisher]
	Physical exercise as a non-pharmacological adjunct in schizophrenia: Effects on molecular and biochemical parameters. Brain Res Cassol G, de Souza MA, da Silva Fiorin F. PMID: 42044735 [PubMed - as supplied by publisher]
	Static and dynamic alterations of local brain activity in schizophrenia and associations with clinical symptoms and cognitive function. Prog Neuropsychopharmacol Biol Psychiatry Wang S, Ren P, Lu C, Zhang X, Dong Y, Liu F, Li S, Li J. PMID: 42044686 [PubMed - as supplied by publisher]
	Orexins, Psychosis, and Antipsychotics: A Systematic Review of Studies of Orexin Levels and the Effects of Dual Orexin Receptor Antagonists (DORAs). Brain Sci Margoni S, Hasaj S, Donofrio G, Kotzalidis GD, Callovini T, Pinto M, Scialpi C, Bucci M, Anesini MB, Sani G, Moccia L, Janiri D. PMID: 42041772 [PubMed]
	Post-Psychotic Depression: A Comprehensive Narrative Review. Diseases Mirkowski KP, Hac KA, Kry, Leszek J. PMID: 42041642 [PubMed]
	An Open-Label, Single-Arm Trial of Transcranial and Intranasal Photobiomodulation in Patients with Schizophrenia: A Study Protocol. Neuropsychiatr Dis Treat Yamada R, Izumi S, Oba MS, Noda T, Stickley A, Sumiyoshi T. PMID: 42038592 [PubMed]
	Peripheral blood immune markers associated with negative symptoms in first episode psychosis: a systematic review. Front Psychiatry Ingabire G, Scarabelot LF, Del-Ben CM, Corsi-Zuelli F. PMID: 42038089 [PubMed]
	Cognitive reserve in non-affective first-episode psychosis: contributions of polygenic scores, early clinical features, and environment. Psychol Med Forte MF, Segura ÀG, Serra-Navarro M, Mezquida G, Torrent C, Gonzalez-Peñas J, Mas S, Vieta E, Andreu-Bernabeu A, Cuesta MJ, Mané A, de la Serna E, Allott K, Bernardo M, Amoretti S, PEPs Group. PMID: 42037495 [PubMed - indexed for MEDLINE]
	Treatment effect modifiers of virtual reality-based versus standard cognitive behavioral therapy for paranoia in schizophrenia spectrum disorders: an exploratory moderator analysis of clinical and demographic characteristics in the FaceYourFears trial. Psychol Med Christensen MJ, Vernal DL, Jeppesen UN, Hjorthøj C, Mainz J, Pinkham A, Austin S, Veling W, Ward T, Nordentoft M, Glenthøj LB. PMID: 42037481 [PubMed - indexed for MEDLINE]
	A Systematic Review of Clinical Phenomenology, Differential Diagnosis and Prognostic Outcomes of Substance-Induced Psychotic Disorders. Int J Soc Psychiatry Ricci V, Martinotti G, Maina G. PMID: 42037032 [PubMed - as supplied by publisher]
	Therapist- and client-rated therapeutic alliance in virtual cognitive behavioral therapy for psychosis: Correlates of alliance and associations with treatment outcomes. Psychother Res Woolridge SM, Vincent NA, Leibovitz T, Jagtap S, Romanowska S, Aidelbaum R, D'Arcey J, Kessaris M, Hamzai HV, Ibrahim AZ, Martins F, Rutledge L, Best MW. PMID: 42036783 [PubMed - as supplied by publisher]
	Psychosis in a 47,XXX Adolescent: Clinical Management and Multidisciplinary Follow-up. Clin Psychopharmacol Neurosci Bain A, Bioulac S, Amblard F, Marey I, Dondé C. PMID: 42036753 [PubMed]

Articles 1 - 20 / 68665

Page 1 of 3434



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy